| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |